MANAJEMEN SYOK KARDIOGENIK PADA ANAK DENGAN PENYAKIT JANTUNG REMATIK
Abstract
Abstrak
Pendahuluan. Penyakit jantung rematik merupakan penyakit dengan angka morbiditas dan mortalitas tinggi sehinggamenjadi tantangan untuk tenaga kesehatan di daerah dengan kondisi sosialekonomi rendah. Hal tersebut disebabkan karena proses penyakit ini yang cenderung bertambah berat dan menetap. Salah satu bentuk komplikasi jangka panjang dari penyakit jantung rematik adalah syok kardiogenik yang sangat mengancam nyawa. Evaluasi yang sistematik dan lengkap tentang riwayat pasien, manifestasi klinik, pemeriksaan fisik yang menyeluruh, serta pemanfaatan alat penunjang medis sangat penting dalam upaya diagnostik PJR. Metode.jurnal ini berbentuk laporan kasus, kami melaporkan kasus syok kardiogenik berulang pada pasien penyakit jantung rematik pada institusi kami. Artikel ini disusun dari berbagai referensi dan pengalaman kasus yang pernah ditangani di Rumah Sakit Tentara Prof. dr. J. A. Latumeten. Hasil. Pada pasien anak dengan syok kardiogenik dan penyakit jantung rematik kami berikan alat bantua napas dan pemberian terapi farmakologi yang sesuai, sehingga dalam 7 hari perawatan kondisi pasien membaik. Kesimpulan Manajemen syok kardiogenik sebagai akibat dari penyakit jantung rematik memerlukan metode diagnostik yang cepat dan tepat. Pemberian terapi berupa farmakologi harus dioptimalkan pada kondisi pasien yang menolak tindakan intervensi bedah sebagai tatalaksana utama.
Downloads
References
Coelho Leal MTB, Coutinho CM, Sá MPBO, et al. Rheumatic heart disease in the modern era: recent developments and current challenges. J Bras Soc Trop Med. 2014 Oct;47(5):567-71. doi: 10.1590/0037-8682-0092-2019. PMID: 25410979.
Kumar RK, Tandon R. Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap. A Scientific Statement From the American Heart Association. Circulation. 2020;132(13):2039-50. doi: 10.1161/CIR.0000000000000298. PMID: 26324545.
Peters F, Stöllberger C, Zouaoui Boudjeltia K, et al. Rheumatic heart disease: current status of diagnosis and therapy. Herz. 2019;44(8):696-702. doi: 10.1007/s00059-019-04807-1. PMID: 31720710.
Chockalingam A, Gnanavelu G, Elangovan S, Chockalingam V. Clinical spectrum of chronic rheumatic heart disease in India. J Heart Valve Dis. 2003 Nov;12(6):577-81. PMID: 14664414.
Remenyi B, ElGuindy A, Smith SC Jr, Yacoub M, Holmes DR Jr. Valvular aspects of rheumatic heart disease. Lancet. 2016 Apr 2;387(10025):1335-46. doi: 10.1016/S0140-6736(16)00547-X. PMID: 27013358.
Kosaraju A, Pendela VS, Hai O. Cardiogenic Shock. [Updated 2022 Jan 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526096/
Rab T, Ratanapo S, Kern KB, Basir MB, McDaniel M, Meraj P, King SB, O'Neill W. Cardiac Shock Care Centers: JACC Review Topic of the Week. J Am Coll Cardiol. 2018 Oct 16;72(16):1972-1980. PMID: 30309471
Maeda K, Takanashi S, Saiki Y. Perioperative use of the intra-aortic balloon pump: where do we stand in 2018? Curr Opin Cardiol. 2018 Nov;33(6):613-621. PMID: 30199444
Kalmanovich E, Audurier Y, Akodad M, Mourad M, Battistella P, Agullo A, Gaudard P, Colson P, Rouviere P, Albat B, Ricci JE, Roubille F. Management of advanced heart failure: a review. Expert Rev Cardiovasc Ther. 2018 Nov;16(11):775-794. PMID: 30295031
Ginwalla M, Tofovic DS. Current Status of Inotropes in Heart Failure. Heart Fail Clin. 2018 Oct;14(4):601-616. PMID: 30219220
Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015;36(18):1115–22.
Beaton A, Okello E, Scheel A, DeWyer A, Ssembatya R, Baaka O, et al. Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting. Heart. 2019;105(10):755–60.
Rothenbuhler M, O’Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health. 2014;2(12):e717–26.
Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acuterheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. doi: 10.1038/nrdp.2015.84.
Jones TD. The diagnosis of rheumatic fever. JAMA. 1944;126:481-484. doi: 10.1001/jama.1944.02850280031010
[No authors listed.] Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1984;69:204A-208A. doi: 10.1161/01.CIR.69.2.204A
[No authors listed.] Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268:2069-2073. doi: 10.1001/jama.1992.03490150087036
[No authors listed.] Jones criteria (modified) for guidance in the diagnosis of rheumatic fever; report of the Committee on Standards and Criteria for programs of care. Circulation. 1956;13:617-620. doi: 10.1161/01.CIR.13.4.617
[No authors listed.] Jones Criteria (revised) for guidancein the diagnosis of rheumatic fever. Circulation. 1965;32:664-668. doi: 10.1161/01.CIR.32.4.664
Cunningham MW. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol. 2014;33:314-329.
Ellis NMJ, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of crossreactive T cell clones from rheumatic heart disease. J Immunol. 2005;175:5448-5456.
Fae KC, Oshiro SE, Toubert A, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol. 2006;176:5662-5670.
Malik MB. Cardiac exam. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553078/
Mustakim MRD. Congestive heart failure et causa rheumatic heart disease. J Kardiol Indon. 2023;4(1):1-6.
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200.
Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. JAHA. [diakses pada 18 Februari 2023]. Tersedia pada: https://www.ahajournals.org/doi/full/10.1161/JAHA.119.012838.
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, MenonV, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017 Nov 14;136(20):e232-e268.
Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003 Jun 24;107(24):2998-3002.
Hasdai D, Holmes DR Jr, Topol EJ. Cardiogenic shock: diagnosis and treatment. Philadelphia: Lippincott Williams & Wilkins; 2003
Barlow JB. Perspective of the Mitral Valve. Philadelphia: FA Davis; 1987. p. 247-50.
Otto CM. Valvular Heart Disease. Philadelphia: WB Saunders; 1999. p. 218.
Sagie A, Freitas N, Padial LR, et al. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease. J Am Coll Cardiol. 1996;28:472-9.
Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic detection of left atrial enlargement: validation by two-dimensional echocardiography. Circulation. 1985;72(4):785-792.doi:10.1161/01.cir.72.4.785
Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37(2):161-186. doi:10.1016/0002-8703(49)90562-1
Ozer N, Cebeci BS, Gurkan K, et al. Electrocardiographic diagnosis of left atrial enlargement and left ventricular hypertrophy. World J Cardiol. 2015;7(9):555-561. doi:10.4330/wjc.v7.i9.555
Reid CL. Echocardiography in patients undergoing catheter balloon mitral commissurotomy. In: Otto CM, ed. The Practice of Clinical Echocardiography. Philadelphia: WB Saunders; 1997. p. 373-88.
Sagie A, Freitas N, Chen MH, Marshall JE, Weyman AE, Levine RA. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. J Am Soc Echocardiogr. 1997;10:141-148. doi: 10.1016/s0894-7317(97)80011-9.
Aschenberg NK, Schluter M, Kremer P, et al. Transesophageal-two-dimensionalechocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol. 1986;7:163-168. doi: 10.1016/s0735-1097(86)80068-8
Koentartiwi D, Candini NA, Indrianto YL, Suwarniaty R. Management of cardiogenic shock in pediatric patients. J Kesehat Islam. 2018;13(2):59-66.
Mendelson J. Emergency Department Management of Pediatric Shock. Emerg Med Clin N Am. 2018;36(2):307-318.
Stephenson M. Understanding shock in children. Br J Nurs. 2020;29(6):350-352.
Zimmerman J, Lee JP, Cahalan M. Vasopressors and inotropes [Internet]. In: Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. 2nd ed. Elsevier Inc.; 2018. p520-534.
Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60:299–308. doi: 10.1136/hrt.60.4.299.
Chatterjee SS, Uddin MJ, Rahman AK, Hussain KS, Rahman MS, Hossain MA, Mitra KK, Saha J, Siddiqui KN, Agarwal D. Percutaneous mitral balloon valvuloplasty in patients with post surgical mitral restenosis: result of 70 cases. Indian Heart J. 2010;62:17–20.
Paiva M, Correia AS, Lopes R, Gonçalves A, Almeida R, Almeida PB, Frutuoso C, Silva JC, Maciel MJ. Selection of patients for percutaneous balloon mitral valvotomy: is there a definitive limit for the Wilkins score? Rev Port Cardiol. 2013;32:873–878. doi: 10.1016/j.repc.2013.02.017.
Vaidya GN, Vaidya PR. Balloon Mitral Valvuloplasty. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441923/
Naik N, Sharma S. Percutaneous Balloon Mitral Valvuloplasty: A Comprehensive Review. J Clin Diagn Res. 2017;11(3):OE01-OE04. doi:10.7860/JCDR/2017/24579.9408
Brissaud O, Botte A, Cambonie G, Dauger S, Blanquat LS, Durand P, Gournay V, Guillet E, Laux D, Leclerc F, Mauriat P, Boulain T, Kuteifan K. Experts’ recommendations for the management ofcardiogenic shock in children. Ann Intensive Care. 2016;6:14. doi: 10.1186/s13613-016-0111-6.
Bernal JL, Peña J, Elizalde JI, et al. Shock and mortality in children with rheumatic heart disease in the 21st century. Pediatr Cardiol. 2015;36(3):446-451.doi:10.1007/s00246-014-1049-9
El-Sisi A, El-Tayeb A, Morsy S, et al. Outcome of medical management of severe rheumatic mitral stenosis in children. Pediatr Cardiol. 2017;38(7):1503-1510. doi:10.1007/s00246-017-1676-1
Copyright (c) 2022 Molucca Medica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
